Before December 7: The Five-Screen Formulary Audit That Prevents a January Copay Shock

Every January, the same scene plays out at pharmacy counters across the country. Someone hands over a card, the tech types for a minute, and then comes the pause. That pause means the drug is not on the plan's list anymore, or it moved to a tier that costs three times as much, or it now needs a prior authorization that nobody bothered to mention in October.

The fix for most of this is boring and it is free: audit the 2027 formulary before the enrollment window closes. For Medicare Advantage and Part D plans, that window shuts on December 7, 2026. For ACA marketplace plans, most states stay open until January 15, 2027 — but a plan that starts January 1 still needs to be locked in by mid-December if you want coverage on day one. Either way, the calendar is shorter than it feels.

Here is the audit, in five screens.

Screen one: the actual drug list, not the brochure

Plans love to send a glossy summary that says something reassuring like our formulary covers thousands of medications. That sentence is technically true and completely useless.

What you want is the full formulary PDF or the plan's online drug search tool. Both are required to be posted, and both are usually buried two clicks deep under a heading like Plan Documents or Prescription Drug Information. If you cannot find it in five minutes, call member services and ask them to email you the direct link — get the link, not a verbal confirmation.

Once you have it, search each of your medications by both brand name and generic name. Written prescriptions and plan databases do not always agree on spelling or capitalization, so try a partial search if the full name returns nothing.

Screen two: the tier, and what the tier actually charges

A drug's tier number by itself tells you almost nothing. Tier 2 on one plan might be a $10 copay; Tier 2 on another might be 25 percent coinsurance with no cap.

So for each medication, write down two numbers: the tier, and the exact dollar or percentage cost-sharing that applies to that tier during the coverage phase you expect to be in. If you take a brand-name drug with no generic equivalent, also check whether the plan applies a deductible to that tier — some do, and a deductible applied to a Tier 3 drug can add several hundred dollars before coverage kicks in at all.

If a drug shows up as not covered, do not stop there. Ask whether it is available through an exception or formulary exception process, and how long that takes. It is usually 72 hours for a standard request and 24 hours for an expedited one, but you want to know before you need it.

Screen three: the fine print attached to each drug

This is the step most people skip, and it is where the nastiest January surprises hide.

Three restrictions matter most:

• Prior authorization. Your doctor has to submit clinical information before the plan will pay. If your prescriber's office is slow in January — and in January, everyone's office is slow — you may be paying cash for a week or two.
• Step therapy. The plan wants you to try a cheaper drug first. If you have already tried it, you will need documentation from your prescriber showing that.
• Quantity limits. The plan caps how much you can fill per month. A 90-day supply may be blocked, or a dose increase may push you over the limit and trigger a rejection that looks, at the counter, exactly like a denial.

Write down which of these apply to which drug. Then, before January, ask your prescriber's office to submit any prior authorization paperwork in December rather than waiting for the rejection. Many offices will do this as a courtesy if you ask early.

Screen four: is your pharmacy still in the network, and at what rate?

Plans renegotiate pharmacy contracts every year, and a pharmacy that was preferred in 2026 can quietly become standard — or out of network — on January 1. Preferred versus standard cost-sharing can be a difference of $10 versus $40 on the same fill, every single month.

Use the plan's pharmacy lookup tool, type in the exact address of the counter you actually use, and check the status. Do this for your backup pharmacy too. Then check whether the plan offers a mail-order rate that beats both; many do for maintenance medications, and the gap is often larger than people expect.

Screen five: the annual math, not the premium

Premiums are the number everyone compares, which is exactly why plans compete on them. What matters is the total: premiums plus expected copays plus any deductible you will realistically hit.

Do this on a single sheet of paper. Twelve months of premium. Twelve months of copays for each medication at the cost-sharing you found in screen two. Add the deductible if you expect to meet it. That total is your real number.

Then repeat the exercise for one alternative plan that covers the same drugs. One is enough — this is a sanity check, not a research project. If the alternative comes in lower by more than a couple hundred dollars, you have your answer.

A useful benchmark: the cash price

Here is one extra number worth scribbling down. For each of your medications, look up the cash price at a local pharmacy using a discount card or a comparison tool. That figure is your floor — the price you would pay with no insurance at all.

It matters for two reasons. First, if your plan's copay is higher than the cash price, you can simply skip the insurance on that fill and save money, which is legal and increasingly common. Second, it tells you whether a plan's negotiated rate is actually a good deal or just a number with a nice font.

If the deadline is this week

Prioritize ruthlessly. Check your two or three most expensive medications first — the ones where a tier change costs the most. A $4 generic moving tiers will not wreck your budget; a $600 brand-name drug moving from Tier 3 to Tier 4 absolutely will.

If you find a problem and cannot resolve it before the deadline, call the plan and ask for the specific reason in writing. A short email asking please confirm in writing whether Drug X is on the 2027 formulary, at what tier, and with what restrictions creates a record you can use later if the answer turns out to be wrong.

The bottom line

Formularies are published documents, not secrets. The January copay shock almost always traces back to a detail that was sitting on the plan's own website in November, unread. An hour with five screens beats a January morning spent arguing with a pharmacy tech who genuinely cannot help you.

Run the audit while the window is open. Your future self, standing at the counter in a puffy coat, will thank you.